Mesenchymal stem cells control alloreactive CD8(+)CD28(−) T cells

CD28/B7 co-stimulation blockade with belatacept prevents alloreactivity in kidney transplant patients. However, cells lacking CD28 are not susceptible to belatacept treatment. As CD8(+)CD28(−) T-cells have cytotoxic and pathogenic properties, we investigated whether mesenchymal stem cells (MSC) are...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Engela, A U, Baan, C C, Litjens, N H R, Franquesa, M, Betjes, M G H, Weimar, W, Hoogduijn, M J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2013
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3826311/
https://ncbi.nlm.nih.gov/pubmed/24028656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12199
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller